Purpose. Pseudomonas aeruginosa expresses a type III secretion system (T3SS) that activates the host inflammasomemediated immune response. We examined the role of inflammasome activation in severe infection outcomes.
INTRODUCTION
The inflammasome is a multi-protein complex that is involved in the innate immune response to many microbial pathogens, including the opportunistic Gram-negative bacterium Pseudomonas aeruginosa [1] . Mammalian cells activate the inflammasome upon the detection of a pathogen-associated molecular pattern (PAMP) in the cytosol [1, 2] . This stimulates a NOD-like receptor such as NLRC4 or NLRP3 to assemble with the canonical inflammasome effector protein pro-casapse-1 through an interaction with the adaptor protein apoptosis-associated speck-like protein containing a CARD domain (ASC) [1, 3] . Assembly of the complex causes caspase-1 to autoproteolytically cleave its regulatory pro-domain, leaving caspase-1 in its active form [3] . Active caspase-1 subsequently cleaves the regulatory pro-domains from the immature cytokines pro-IL-18 and pro-IL-1b [4] . Mature IL-18 and IL-1b are then released from the cell to propagate the downstream immune response [4, 5] . Caspase-1 also results in programmed cell death by pyroptosis [1] . In this way, detection of P. aeruginosa by the host is transduced into a robust immune response through activation of the inflammasome.
One virulence mechanism that P. aeruginosa uses to promote infection is the type III secretion system (T3SS). The T3SS forms a needle-like apparatus that injects effectors directly into the cytosol of host cells following contact with bacteria [6] . P. aeruginosa secretes four major effectors via the T3SS: ExoU, ExoS, ExoT and ExoY [6] . ExoU has phospholipase A 2 activity and results in the rapid lysis of target cells [6] . ExoT and ExoS share a high degree of sequence similarity with each other [6] and are bi-functional proteins with ADP-ribosyltransferase (ADPRT) and GTPase activity protein (GAP) domains [6] . ExoY has adenylyl cyclase activity [6] . Together, these effectors modulate a number of aspects of host cells to facilitate P. aeruginosa infections [6] . While nearly all P. aeruginosa clinical isolates encode the exoT gene, the genes encoding exoS and exoU are usually mutually exclusive, with approximately 70 % of strains encoding exoS and 30 % encoding exoU [7] .
In addition to its virulence functions, the T3SS also serves as a ligand for immune recognition by the inflammasome. Mammals have evolved specific NLR family apoptosis inhibitory proteins (NAIPs) that sense components of the T3SS apparatus during P. aeruginosa infection [8, 9] . Notably, murine NAIP2 binds to PscI, the inner rod protein of the T3SS apparatus [8, 9] , while murine NAIP1 and human NAIP bind to PscF, the primary needle protein [9, 10] . Upon sensing the ligand, NAIPs interact with NLRC4 to initiate the inflammasome assembly cascade [8, 9, 11] . Interestingly, the T3SS effectors ExoU and ExoS have been shown to dampen the inflammasome-mediated immune response [12, 13] . ExoU inhibits the maturation of caspase-1 and dampens caspase-1-dependent IL-1b release [12] . Similarly, ExoS also dampens IL-1b release [13] by shifting the immune response towards a caspase-3-mediated mechanism of programmed cell death by apoptosis [13] . Hence, the T3SS promotes infection through the effectors that it secretes, stimulates the host inflammasome-mediated immune response and modulates inflammasome activity through the effector proteins ExoU and ExoS.
It must be noted that cell death is not inherently disadvantageous with respect to the host immune response. Indeed, caspase-1-dependent pyroptosis, which is characterized by membrane damage and lysosomal exocytosis [14] , is important for bacterial clearance of intracellular Salmonella enterica, Legionella pneumophila and Burkholderia thailandensis [15] . Caspase-1-dependent pyroptosis also results in the release of antimicrobial peptides into the extracellular milieu through lysosomal exocytosis [14] . In this way, pyroptosis could affect extracellular bacteria such as P. aeruginosa. Conversely, caspase-3/7-mediated cell death releases the cellular contents contained in apoptotic bodies to be engulfed by neighbouring cells [16] . As mentioned above, ExoS shifts the immune response from caspase-1 to caspase-3 activation pathways [13] . This shift in cell death pathways could have the dual effect of dampening IL-1b production and protecting bacteria from the damaging intracellular compounds released by pyroptosis.
There is mounting evidence that inflammasome activation by P. aeruginosa is associated with increased bacterial persistence and host tissue damage [17] [18] [19] . Studies featuring either mice lacking NLRC4 or treatment with chemical inhibitors to block capsase-1, IL-1b and IL-18 have demonstrated improved bacterial clearance and reduced infectionrelated tissue damage [17, [19] [20] [21] . Others have shown that neutrophils secrete IL-1b independently of caspase-1 [22] or the inflammasome adaptor protein ASC [23] in response to P. aeruginosa infection. Thus, it is unclear whether the inflammasome or inflammasome-independent processes contribute to poor infection outcomes. Taken together, these studies highlight the ongoing questions regarding the role of the canonical caspase-1-dependent inflammasome in cell death, IL-b release and infection outcomes during P. aeruginosa infection.
The goal of the current study is to examine the implications of inflammasome activation in a mouse model of acute pneumonia using a highly virulent clinical isolate of P. aeruginosa, PSE9. PSE9 had previously been shown to be the most virulent strain of a panel of 35 P. aeruginosa isolates cultured from patients with ventilator-associated pneumonia [24] . We describe a novel role for the inflammasome adaptor protein ASC in contributing to the severity of PSE9 infection. Furthermore, we provide evidence that caspase-3/7 is active during PSE9 infection and that this activity is dependent on ASC. Collectively, we demonstrate that parallel cell death pathways are activated by P. aeruginosa during acute pneumonia that exacerbate infection outcomes in mice.
METHODS

Mice
The mice for these experiments included 6-to 10-week-old C57BL/6NJ, Casp1/11 À/À , IL-18 À/À , NLRP3 À/À and caspase-11 À/À mice (Jackson Laboratories). The ASC À/À mice were a gift from Genentech. The control mice were age-and gender-matched. All experiments were conducted under the supervision and with the approval of the Northwestern University Animal Care and Use Committee.
Bacterial strains P. aeruginosa strains were plated on Vogel-Bonner medium (VBM) agar and incubated at 37 C overnight before inoculation into Luria-Bertani (LB) liquid medium or MINS medium [25] . PSE9, an exoS + clinical isolate, was originally cultured from the respiratory tract of a patient with ventilator-associated pneumonia [26] . The gene encoding pscF was deleted from strain PSE9 by allelic exchange according to published methods [27] . Briefly, an in-frame deletion was created by cloning 100 bp of the 5¢ and 3¢ gene regions with overlapping complementary regions using PCR SOEing (5¢ forward primer -aaaaaagcttcagcgctacctcgatggcag, reverse -agtgtccatgttcagatcttctgcgccatgcttagtcctc; 3¢ forward primer -gaggactaagcatggcgcagaagatctgaacatggacact, reverse -aaaaaagatttgggatcgtcgccgggc). After isolating the cloned gene fragment by gel electrophoresis, the fragment was digested with the restriction enzymes HindIII (New England Biolabs) and EcorV (New England Biolabs) and ligated into a similarly digested pEX18Gm vector containing a gentamicin resistance gene and the sacB counter-selection gene with T4 DNA ligase (New England Biolabs). The resultant pEX18:DpscF plasmid was transformed into competent S17.1+Esherichia coli and mated for approximately 12 h with PSE9 on LB agar plates. LB agar plates containing 50 µg ml À1 gentamicin were used to select PSE9 strains that had integrated the deletion vector. The vector backbone was resolved by selection on LB agar containing 6 % sucrose. PSE9 strains that retained the DpscF allele were verified by sequencing the pscF gene region and by whole-genome sequencing.
P. aeruginosa strain PA99 is a clinical isolate that was originally cultured from the urine of a patient with a urinary tract infection [28] . The mutants in this strain background were previously generated and characterized [28] .
Mouse infections
Bacterial cultures were grown at 37 C with shaking overnight in MINS medium. A 350 µl aliquot was then subcultured into 5 ml of fresh medium and allowed to grow for an additional 2-4 h until an appropriate bacterial density was reached during the exponential growth phase. Bacteria were resuspended in sterile PBS to determine bacterial numbers by optical density, aiming for approximately 1.2Â10 7 colony-forming units (c.f.u.) per ml. Prior to infection, mice were anaesthetized by intraperitoneal injection of a cocktail of 100 mg ml À1 ketamine and 20 mg ml À1 xylazine. Approximately 3.5Â10 5 (or 5.5 logs) c.f.u. in 30 µl volume were administered to the nares of anaesthetized mice. Bacterial numbers were verified by counting serial dilutions of the inoculum on LB plates. For survival experiments during acute pneumonia, mice were monitored for illness over a period of 96 h. Mice that demonstrated severe illness by predetermined criteria were humanely euthanized and scored as mortalities. For bacterial persistence assays, mice were humanely euthanized at the indicated times, and organs were removed and homogenized in 5 ml sterile PBS. Serial dilutions of organ homogenates were plated on LB agar. c.f.u. were counted to quantify viable bacteria present in the organs.
Cell culture
Macrophages were differentiated from bone marrow as previously described [29] . Briefly, bone marrow was isolated from the femur of mature mice (>6 weeks old) and cultured in Petri dishes with RPMI medium supplemented with 30 % L cell supernatants and 20 % foetal bovine serum (FBS). Cells were incubated at 37 C in 5 % CO 2 with humidity. Fresh growth medium was added after 3 days. After 7 days of growth, non-adherent cells were washed away with spent medium. Adherent cells were scraped from the culture dish and resuspended in fresh RMPI medium supplemented with 10 % L cell supernatants and 10 % FBS. Cells were counted and seeded at a density of 1Â10 6 
Cell culture infections
Bacteria for cell culture infections were prepared with the same method as described for animal experiments. Within 30 min to 1 h prior to infection, cell medium was removed and replaced with serum-free RPMI medium. Cells were infected with appropriate volumes to result in a multiplicity of infection (m.o.i.) of 25 and mixed thoroughly by gentle pipetting. Bacterial numbers were verified by counting colonies from plated serial dilutions of the inoculation volume. Samples of infected culture supernatants were collected at the indicated times for cytotoxicity assays or cytokine quantitation. Cytotoxicity assays were conducted in 12-well plates and quantified using a Cytotox-96 kit (Promega) according to the manufacturer's instructions. Cytokine release assays were conducted in 96-well plates and quantified by IL-18 ELISA (MBL International) or IL-1b ELISA (R&D Systems) according to the manufacturer's instructions. Where indicated, cells were preincubated for 1 h prior to bacterial inoculation with YVAD (Cayman Chem), DEVD (Cayman Chem), IETD (R&D Systems) or ATAD (R&D Systems) reconstituted in dimethyl sulfoxide (DMSO) at a final concentration of 100 µM in serum-free RPMI medium. Bioluminescent reporter assays were conducted in 12-well plates using Caspase-Glo 1 and CaspaseGlo 3/7 Inflammasome Assay kits (Promega) according to the manufacturer's instructions.
Immunoblot analyses
Active and inactive caspases in BMDMs were detected by immunoblot analyses. Briefly, cells were plated in full-sized plates (for caspase-1) or six-well plates (all other caspases) and infected for the indicated times at an m.o.i. of 25. The full volume of culture supernatant was collected, and proteins were precipitated by 10 % trichloroacetic acid (TCA) at 4 C overnight with mixing. Precipitated proteins were resuspended in 1.5 ml 10 mM NaCl. Cells were rinsed with cold PBS and resuspended in RIPA buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 2 mM EDTA, 0.2 % Triton X100, 0.3 % NP-40, 25 mM NaF, 0.1 mM Na orthovanadate, 0.25 % Na deoxycholate] with a dissolved cOmplete protease inhibitor tablet (Sigma-Aldrich). Cells were then lysed by passage through a needle, and lysate was placed on ice. Cell debris was pelleted. Forty millilitres of either cell lysate or culture supernatant was mixed with 6Â protein loading dye, boiled for 2 min and loaded onto a 15 % SDS-polyacrylamide gel. After electrophoresis, samples were transferred to a nitrocellulose membrane for the detection of protein bands. Blots were blocked with either 10 % milk buffer or bovine serum albumin (BSA), according to the antibody supplier's recommendation. The following primary antibodies were used: rabbit anti-caspase-1 (5 µg; EMD Millipore), rabbit anti-b-actin (1 : 1000 dilution; Abcam), rabbit anticaspase-3 (1 : 500 dilution; Cell Signaling Technologies), rabbit anti-caspase-8 (1 : 500 dilution; Cell Signaling), rabbit anti-caspase-9 (1 : 500 dilution; Cell Signaling) and rabbit anti-caspase-12 (1 : 500 dilution; Cell Signaling). Goat antirabbit IgG antibody conjugated to horseradish peroxidase (1 : 5000 dilution; Jackson ImmunoResearch Laboratories) was used for secondary detection followed by incubation with Super Signal West Dura (Thermo Fisher) for development.
Statistical analysis
The statistical significance of differences in mouse survival were determined by the Kaplan-Meier log-rank test for equality. Bacterial burdens in the lungs were evaluated with the Kruskal-Wallis equality of populations rank test; pairwise comparisons between groups were evaluated by Fisher's exact test of the medians. The figures represent combined data from at least two independent experiments. Cell death and cytokine release in vitro were analysed by analysis of variance (ANOVA) with Bonferroni adjustment of pairwise comparisons. In all cases, tests with a P value <0.05 were deemed statistically significant results. For the data figures for in vitro experiments, the bars represent the means of conditions in triplicate and the error bars are standard deviations.
RESULTS
P. aeruginosa promotes infection through ASC
To examine the implications of inflammasome activation in vivo, we intranasally infected wild-type C57BL/6 mice (B6), ASC-deficient mice (ASC À/À ) and caspase-1/11-deficient mice (C1/11 À/À ) with a highly virulent ExoS + clinical strain of P. aeruginosa, PSE9 (24) . We hypothesized that ASC À/À and caspase-1/11 À/À mice would be equally susceptible to infection because ASC is upstream of caspase-1 in inflammasome assembly. However, ASC is not required for all caspase-1 effector functions [3, 30] . Therefore, we compared survival and bacterial clearance from B6, ASC À/À and C1/ 11 À/À mice to parse out the consequences of inflammasome activation in vivo. Under these infection conditions, PSE9 was highly lethal to B6 mice. An inoculum of 3.5Â10 5 c.f.u. caused nearly all mice to develop pre-lethal illness within 96 h (Fig. 1a, b) , and bacteria persisted in high numbers in the lungs up to 30 h post-infection (p.i.) (Fig. 1c) . Pre-lethal illness of ASC À/À mice infected with PSE9 was delayed by approximately 18 h compared to B6 control mice, and the overall survival of ASC À/À mice was 46 % (Fig. 1b) . Consistent with these findings, 80 % of ASC À/À mice exhibited a reduction in bacterial numbers in their lungs by 30 h p.i. (Fig. 1c) . These findings were not the result of less efficient deposition of the bacterial inoculum into the lungs of mice, as equivalent c.f.u. were recovered from the lungs of B6 and ASC À/À mice at 30 min p.i. (Fig. S1 , available in the online version of this article). These data demonstrate that ASC is detrimental to infection outcomes, as mice lacking the inflammasome adaptor protein had improved survival and reduced bacterial burden in the lungs compared to B6 control mice. In contrast, B6 mice infected with a PSE9 strain lacking a T3SS needle due to a disruption of the pscF gene (PSE9DpscF) survived the infection time course (Fig. 1a) . PSE9DpscF numbers in the lungs were reduced as early as 24 h p.i. in B6 mice (Figs 1d and S1). These results indicate that the T3SS contributes significantly to the virulence of PSE9. Interestingly, C1/11 À/À mice infected with PSE9 were as susceptible to infection as B6 control mice (Fig. 1b) . Although the median bacterial burden in the lungs of C1/ 11 À/À mice was reduced by over 1 log compared to B6 mice at 30 h p.i., the difference was not statistically significant (Figs 1c and S1 ). Therefore, we concluded that caspase-1/11 did not make a significant contribution to poor infection outcomes during pneumonia caused by PSE9, because the absence of caspase-1/11 did not improve survival or significantly reduce bacterial clearance.
We next investigated possible mechanisms by which ASC could contribute to severe infection outcomes in mice infected with PSE9. ASC is required for processing IL-18 and IL-1b cytokines that contribute to a pathological immune response to P. aeruginosa [3, [17] [18] [19] 21] . However, the fact that caspase-1/11 À/À mice did not have improved outcomes suggested that the ASC-induced survival benefit was not due to inflammasome-dependent cytokines. To verify this in vivo, IL-18 À/À mice were infected with PSE9. We observed that IL-18 À/À mice succumbed to infection within 48 h and exhibited no significant survival improvement compared to B6 mice (Fig. 2) . Therefore, loss of IL-18 did not attenuate infection, as was observed with ASC. Taken together, these results suggest that PSE9 is activating an ASC-dependent immune response that is detrimental to outcomes but independent of caspase-1 and IL-18.
P. aeruginosa engages the canonical inflammasome pathway in vitro Given the uncoupling of ASC from caspase-1 in vivo, we next assessed the nature of inflammasome activation in vitro to determine whether PSE9 engaged the canonical caspase-1 pathway in a novel way. Cell death and cytokine release were assessed in vitro with bone marrow-derived macrophages (BMDMs) from B6 mice. Infection of B6 BMDMs with the parental strain PSE9 for 2.5 h resulted in 60 % cell death (Fig. 3a) . Infection with PSE9DpscF demonstrated that the T3SS was required for a significant portion of this cell death (Fig. 3a) . T3SS-dependent killing could be due to the direct toxicity of injected effector proteins or the host pyroptotic cell death response. To distinguish between these two possibilities, we infected BMDMs from mice lacking components of the inflammasome pathway. Cell death was reduced by 50 % in ASC À/À BMDMs infected with PSE9 relative to B6 BMDMs and was nearly abrogated in C1/11 À/À BMDMs (Figs 3b, S2a and b) . However, cell death was independent of cytokine release, as IL-18À/À BMDMs were susceptible to PSE9 infection (Fig. 3b) . These results indicate that PSE9 killing of macrophages occurs through a caspase-1/11-mediated process that is partially dependent upon ASC. These findings are consistent with prior reports of P. aeruginosa activation of the inflammasome pathway to cause pyroptosis [9, 17, 29, 31] .
Another indication of canonical inflammasome activation is cleavage of the regulatory pro-domain from caspase-1. Autoproteolytic cleavage and activation of pro-caspase-1 releases the 10 and 20 kDa active protein fragments. We looked for evidence of caspase-1 activation following PSE9 infection of B6 BMDMs by immunoblot and detected a faint band corresponding to the 20 kDa (p20) protein fragment in culture supernatants (Fig. S3) . Furthermore, both IL-18 and IL-1b were detectable in culture supernatants (Fig. 3c,  d , respectively). IL-18 and IL-1b were still detectable, albeit significantly reduced, in PSE9DpscF-infected B6 BMDMs compared to those infected with PSE9, demonstrating that type III secretion is required for the release of some of the cytokines. IL-18 and IL-1b release was significantly attenuated in PSE9-infected BMDMs lacking ASC relative to B6 (Fig. 3c, d, respectively) . Cytokine release was nearly completely eliminated in caspase-1/11 À/À macrophages (Fig. 3c, d ). Taken together, these results are consistent with the current model of the canonical inflammasome activation in which PSE9 infection leads to caspase-1 activation and cytokine release in a process that requires ASC [3] . While type III secretion is a robust ligand of inflammasome activation, as evidenced by the enhancement of pyroptosis and cytokine release when the T3SS is intact, other components of PSE9 may also play a role. With regard to the current study, these results further suggest that the unexpected role of ASC in vivo (Fig. 1b) cannot be explained by aberrant activation of the canonical inflammasome or caspase-1 effector functions in macrophages because our in vitro results are consistent with the published literature.
The non-canonical caspase-11 pathway is not required for PSE9-mediated cell death or cytokine release The caspase-1 À/À mice used in this study also harbour a mutation in the gene encoding caspase-11 [30] . Caspase-11 functions as a non-canonical inflammasome and contributes indirectly to IL-1b release through IL-1a autocrine signalling and modulation of caspase-1 [30] . Previous studies indicated that caspase-11 is not activated by P. aeruginosa [17, 30] . Nevertheless, we evaluated activation of the noncanonical inflammasome to ensure that our previous results were not confounded by activity of caspase-11. We hypothesized that if the non-canonical inflammasome were activated downstream of ASC, cell death and cytokine release from caspase-11 À/À BMDMs would replicate results from our ASC À/À BMDMs.
Caspase-11 is activated by Gram-negative bacteria through TLR4 engagement that leads to NF-kB mediated transcription and subsequent translation of NLRP3 [32, 33] . Therefore, BMDMs were isolated from mice with genetic disruptions of the genes encoding NLRP3 and caspase-11 to observe cell death and cytokine release in the absence of the non-canonical inflammasome. Unlike the ASC À/À and caspase-1/11 À/À BMDMs described above, both caspase-11
and NLRP3 -À/À BMDMs exhibited cell death at similar levels to B6 BMDMs upon PSE9 infection (Figs 4a, S2c and d) . Furthermore, both genotypes were competent to release IL-18 and IL-1b (Fig. 4b, c, respectively) . In fact, both caspase-11 À/À and NLRP3 À/À BMDMs released more of these cytokines relative to the B6 controls (Fig. 4b, c) . The current findings suggest that caspase-11 and NLRP3 may be involved in dampening inflammatory cytokines IL-18 and IL-1b upon the detection of P. aeruginosa because BMDMs deficient in either component exhibited enhanced cytokine release (Fig. 4b, c) . Regardless, it is clear that ASC is not acting through caspase-11 and NLRP3, as neither NLRP3 À/À nor caspase-11 À/À BMDMs replicated the results for our ASC À/À BMDMs reported above (Fig. 3b-d) . Therefore, we conclude that the non-canonical inflammasome is not activated downstream of ASC by PSE9 and does not account for the in vivo role of ASC.
Caspase-3/7 is activated in parallel to caspase-1 during PSE9 infection To this point, we have demonstrated that the canonical caspase-1-dependent inflammasome is activated in the context of PSE9 infection (Fig. 3) , but that elimination of this pathway does not ameliorate the lethality of infection in vivo (Fig. 1b) . However, the elimination of ASC does ameliorate the lethality of PSE9 infection in vivo (Fig. 1b) , suggesting that ASC may be worsening infection through a caspase-1-independent pathway. One possibility is that PSE9 engagement of ASC has consequences for caspases in addition to caspase-1. Heterotypic interactions of ASC with caspase-8 have been reported [34] , and PSE9 secretes the T3SS effector ExoS (Fig. S4) , which activates caspase-3 to cause apoptosis [13] . We evaluated PSE9-mediated activation of other caspases by immunoblot analysis. The active fragments of caspase-9, caspase-12, caspase-8 and caspase-3/7 were all detected in uninfected cells, likely due to programmed cell death mechanisms intrinsic to the cellular lifecycle (Fig. 5a ). We were unable to detect the active fragment of caspase-9 or caspase-12 in PSE9-infected BMDMs (Fig. 5a) . Indeed, caspase-12 appears to be inhibited during PSE9 infection. The active fragments of both caspase-8 and caspase-3/7 were present in PSE9-infected cells (Fig. 5a ). These observations suggested that changes to caspase-3/7 or caspase-8 activation could explain our previous findings if the activity of these caspases is dependent on ASC. It was unclear, however, whether either of these caspases were activated in response to PSE9, or whether their detection was again due to background levels of programmed cell death.
Our previous in vitro assays did not detect substantial cell death independent of caspase-1/11 (Fig. 3b) , but we reasoned that pyroptosis could be masking cell death caused by caspases other than caspase-1. To determine whether the activation of caspase-8 or caspase-3/7 contributed to cell death during PSE9 infection, we infected caspase-1/11
BMDMs with PSE9 and measured cell death by LDH release at 4 h (rather than 2.5 h, as used in Fig. 3) . Indeed, at this later time point caspase-1/11 À/À BMDMs were killed by PSE9 (approximately 80 % cell death, Fig. 5b ). To address whether other caspases played a role in this killing, we included inhibitors of caspase-12 (z-ATAD), caspase-8 (z-IETD) or caspase-3/7 (z-DVD) in the media during co-incubation of BMDMs with PSE9. Although caspase-8 and caspase-12 inhibitors reduced cell death by half in response to apoptosis induction by staurosporine (Fig. 5c) , cell death in response to PSE9 infection was only marginally reduced with these inhibitors (Fig. 5b) , and the differences were not statistically significant. However, the addition of the caspase-3/7 inhibitor z-DEVD significantly reduced cell death in response to both staurosporine and PSE9 infection (Fig. 5b, c, respectively) . This result suggested that caspase-3/7 is activated in response to PSE9. Given the difference in timing between these experiments and our previous assays (Fig. 3) , we repeated this experiment with B6 BMDMs using a 2.5 h infection to determine whether caspase-3/7 inhibition reduced cell death at earlier time points and in the presence of caspase-1. PSE9 infection of B6 BMDMs treated with z-YVAD to inhibit caspase-1 predictably reduced cell death (Fig. 5d) . Furthermore, z-DEVD treatment also significantly reduced cell death of PSE9-infected B6 BMDMs (Fig. 5d) . These results suggest that caspase-3/7 contributes to cell death during PSE9 infection even when caspase-1 is present and active.
Caspase-3/7 activity is reduced in the absence of ASC Consistent with the reports of others [13] , we have demonstrated that the caspase-3/7 pathway is active during P. aeruginosa infection in vitro. However, it is unclear whether ASC contributes to the caspase-3/7 cell death pathway. To address this question, we utilized a bioluminescent reporter assay to measure caspase activity in vitro. First, we assessed the activity of caspase-1 using this technology (Figs 6a and S5a). Whereas B6 BMDMs infected with PSE9 demonstrated a 10-fold increase in caspase-1 activity relative to uninfected macrophages, cells infected with PSE9DpscF exhibited a much smaller 2.5-fold increase in caspase-1 activity (Figs 6a and S5a) . Moreover, caspase-1 activity was not detected above background levels in BMDMs lacking ASC (Figs 6a and S5a) . Notably, this assay detects cleaved caspase-1, which has been shown to require ASC [3] . Therefore, these results are consistent with our findings and with previous studies showing that caspase-1 activation is ASC-dependent.
We next turned to the question of caspase-3/7 activity in the absence of ASC. We anticipated that caspase-3/7 activity as measured by the bioluminescent reporter would be reduced in the absence of ASC if the adaptor protein interacts with the apoptotic pathway upstream of caspase-3/7. Overall, we did not observe the same magnitude of activation for caspase-3/7 (Figs 6b and S5b) compared to caspase-1 (Fig. 6a) . Caspase-3/7 activity was enhanced 2.5-fold in B6 BMDMs infected with PSE9, but was not enhanced in ASC À/À macrophages (Figs 6b and S5b). Based on these findings, we conclude that caspase-3 activation is dependent on the presence of ASC. Furthermore, this interaction demonstrates an alternative role for ASC during P. aeruginosa infection.
Functional type III secretion is required for caspase activation Although ExoS is secreted in a T3SS-dependent manner, this effector protein and the needle apparatus have different effects on inflammasome activation and cell death during infection [8, 9, 13, 31, 35] . We sought to determine whether our observed ASC-dependent caspase-3/7 activation was due to the T3SS apparatus or the ExoS effector. To do so, we utilized a panel of previously characterized T3SS mutants in a P. aeruginosa strain PA99 background: PA99S, which secretes only ExoS; PA99null, which produces a functional TSS apparatus but does not secrete any effectors; and PA99DpscJ, which lacks a functional T3SS (S4) [28] . First, we assessed these mutants in vitro by infecting B6 BMDMs and ASC-deficient BMDMs and measuring cell death by LDH release (Fig. 7a) . B6 BMDMs were susceptible to cell death when infected with PA99S and PA99null (Fig. 7a) . However, cell death was abrogated in cells infected with PA99DpscJ, consistent with our previous findings that a functional T3SS is required for cell death. Furthermore, cell death was significantly reduced, but not eliminated, in ASC À/À BMDMs infected with PA99S and PA99null (Fig. 7a) . These results are consistent with our conclusion that an ASC-dependent pathway or pathways contribute to the cell death of macrophages during P. aeruginosa infection.
We reasoned that if ExoS were responsible for the observed activation of caspase-3/7 ( Figs 5 and 6b) , then caspase-3/7 activity would be similarly abrogated in cells infected with PA99null and PA99DpscJ, since both mutants fail to secrete ExoS. As observed in the PSE9 background, caspase-1 and caspase-3/7 were both activated by PA99S in B6 BMDMs, but enhanced caspase activation was lost in macrophages infected with PA99DpscJ (Fig. 7b, c) . When evaluating the role of the T3SS in the absence of ExoS (i.e. the PA99null strain), we observed substantial activation of both caspase-1 and caspase-3/7 (Fig. 7b, c, respectively) . The activation of both caspases was lower than that observed with the PA99S strain, although the reduction of caspase-3/7 was not statistically significant (Fig. 7c ). These results demonstrate that the presence of the T3SS apparatus in the absence of effectors is sufficient to stimulate the activation of caspase-1 and caspase-3/7. Furthermore, both caspase-1 and caspase-3/7 activation were lost in ASC À/À BMDMs in all conditions tested (Figs 6a, b and 7b, c) . These results demonstrate that the P. aeruginosa T3SS activates both the pyroptotic and apoptotic mechanisms of programmed cell death, and that both pathways are dependent on the adaptor protein ASC.
We reasoned that if abrogation of the ASC-and caspase-3/ 7-dependent pathway accounted for the improved outcomes observed in P. aeruginosa-infected ASC À/À mice (Fig. 1b, c) , and the T3SS activated this pathway, then infection with a strain of P. aeruginosa that lacked a functional T3SS would no longer show improved outcomes in ASC À/À mice. We wished to test this experimentally. Comparing the survival of B6 and ASC À/À mice infected with PSE9DpscF, however, would be uninformative, since infection with this attenuated strain of P. aeruginosa would likely yield 100 % survival in both groups (Fig. 1a) . We therefore quantified bacterial numbers in the lungs. No statistically significant difference in the recovery of c.f.u. from the lungs of B6 and ASC À/À mice was observed at 24 h p.i. (Fig. 1d) . This observation is consistent with the hypothesis that activation of the ASC-and caspase-3/7-dependent pathway by the P. aeruginosa T3SS causes more severe pneumonia in the mouse model.
DISCUSSION
We uncovered a novel role for the inflammasome adaptor protein ASC in promoting severe infections in vivo. Using a mouse model of acute pneumonia, we showed that mice lacking ASC had improved survival and that 80 % of these mice had reduced numbers of bacteria in their lungs. These results demonstrate that ASC is detrimental to infection outcomes because bacterial clearance and host survival are improved in the absence of ASC. Importantly, these results did not correspond to those for mice lacking caspase-1/11, indicating that these factors impact on the host response to P. aeruginosa in different ways. Additional in vitro findings were consistent with ASC-mediated activation of caspase-3/ 7 playing a role in the response to P. aeruginosa, although examining this relationship in vivo remains challenging because caspase-3/7 is essential for development and is thus embryonic lethal. Our results advance the understanding of the cross-talk between cell death pathways during P. aeruginosa infection and add to the expanding body of literature indicating that inflammasome responses extend beyond the simple canonical caspase-1 inflammasome to include multiple receptors [8, 9, 36] , non-canonical caspase-11 [30, 33] and caspase-1 independent IL-1b release [22, 23] .
To explore how ASC was impacting on infection in vivo, we examined multiple aspects of inflammasome activation in vitro, including caspase-1-mediated cell death, cytokine release and the contributions of the non-canonical caspase-11 inflammasome pathway. We found that P. aeruginosa infection of BMDMs resulted in caspase-1-dependent cell death and the release of IL-18 and IL-1b, which are indicative of inflammasome activation. While cell death was partially reduced in the absence of ASC, cytokine release was nearly abrogated in the absence of ASC. These results are consistent with reports that P. aeruginosa activates the NLRC4 inflammasome, which requires ASC for caspase-1-dependent proteolytic processing of IL-18 and IL-1b, but which is capable of initiating pyroptotic cell death in the absence of ASC [3, 12, 29] . These findings, however, did not explain our in vivo results. This led us to the conclusion that P. aeruginosa engages an alternative ASC pathway that is detrimental to infection outcomes and is independent of the caspase-1 inflammasome.
Our results expand on recent findings that ASC is capable of interacting with caspases other than caspase-1. Lee and colleagues described a reduction in caspase-3 activity in the absence of ASC when human monocyte-like THP1 cells were stimulated with shiga toxin [37] . Similarly, we found that P. aeruginosa caused caspase-3 activation in a process facilitated by ASC. (Notably, the caspase-3 inhibitors, antibodies and assays used in this study and others have crossreactivity with caspase-7. We focus on the role of caspase-3 in P. aeruginosa infection based on the body of evidence in the published literature.) Taken together, caspase-3 plays multiple roles in the pathogenesis of P. aeruginosa infections. The ADPRT activity of ExoS induces caspase-3 activity and cell death by apoptosis in infected HELA cells [38] . The work of Galle et al. was the first to demonstrate that ExoS promotes caspase-3-dependent cell death in the context of caspase-1 activation [13] . We found that a functional T3SS is sufficient to activate caspase-3/7. Furthermore, we found that T3SS activation of caspase-3/7 is dependent on ASC and activation occurs in parallel to ASC-dependent caspase-1 activation. Finally, we did not observe a statistically significant difference in pulmonary bacterial loads between B6 and ASC À/À mice when the infecting bacteria lacked a functional T3SS, suggesting that the detrimental ASC-caspase-3/7 pathway is activated by this secretion system. Additional work is required to fully understand the implications of dual cell death pathways involving caspase-1 and caspase-3/7 for host infection outcomes.
In the current study, we used an isolate, PSE9, which was noted to be the most virulent of 35 tested ventilatorassociated pneumonia isolates in a mouse model [24] . In this regard, PSE9 is a relevant strain, as it was cultured from a patient with ventilator-associated pneumonia. Although clinical isolates of P. aeruginosa have been reported to activate the inflammasome and induce IL-1b [39] , most prior studies of inflammasome activation used laboratory-adapted strains of P. aeruginosa [1, 3, 8-10, 17, 29, 36] . However, the highly pathogenic nature of PSE9 suggests that it has multiple mechanisms to enhance disease progression, and other strains may lack some of these mechanisms. Further studies are necessary to determine whether P. aeruginosa clinical isolates of lesser virulence activate the host inflammasome in a similar manner.
In summary, P. aeruginosa T3SS affects disease pathogenesis in multiple ways (Fig. 8): (1) by direct toxicity and manipulation of cellular components by the effector proteins ExoU, ExoS, ExoT and ExoY [6] ; (2) by enhancing the host immune response through the caspase-1-dependent inflammasome [17, [19] [20] [21] 31] ; and (3) by inducing caspase-3-dependent cell death. The last form of cell death is activated either by ExoS [13, 38] or a T3SS-dependent but ExoS-independent process. Furthermore, ASC plays complex roles in cell death processes as an adaptor protein for the caspase-1-dependent inflammasome and in the activation of caspase-3. Further understanding of the pathways activated by P. aeruginosa T3SS may aid the development of new therapies [40] [41] [42] [43] [44] . 
